Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ocugen, Inc. Director's Dealing 2019

Dec 5, 2019

32915_dirs_2019-12-05_d890b244-9953-4cd5-98b9-f8447101a42a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-12-04

Reporting Person: Zhang Junge (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-04 Common Stock P 220000 $.44 Acquired 818578 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 212863 Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.43 to $0.44. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4.

F2: The amount in Column 5 reflects the deduction of 1,500 shares to correct an error in the reporting person's Forms 4 filed on November 20, 2019, November 26, 2019 and December 2, 2019, in which the number of shares beneficially owned by the reporting person following those dates were over-reported by 1,500 shares.